Autopsy report · NCT02638129
Naltrexone/Bupropion Cardiovascular Outcomes Study
Cause of deathNo reason given
Life of this trial
- Ran for about 5 months before it stopped.
- 67 participants enrolled.
- Results were posted on the registry 8 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Orexigen Therapeutics, Inc
- Sponsor type
- Industry
- Conditions
- Obesity; Cardiovascular Diseases
- Interventions
- Naltrexone HCl/Bupropion HCl ER; Placebo
- Participants
- 67
- Sites
- 139
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.